Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 4 | M-CSF | 318.5 | 36 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | M-CSF | 295.0 | 35 | ||||
RA2708 | 4 | M-CSF | 291.0 | 54 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 290.5 | 52 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 310.0 | 45 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 252.0 | 60 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 276.0 | 55 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 272.5 | 52 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 227.5 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 398.5 | 60 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 398.5 | 54 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 343.0 | 41 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 298.0 | 53 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 277.5 | 50 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | M-CSF | 227.0 | 38 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 408.0 | 49 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 362.5 | 40 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 319.0 | 51 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 401.5 | 52 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 407.5 | 52 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 497.0 | 45 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 602.0 | 52 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 626.0 | 39 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 730.5 | 46 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | M-CSF | 722.0 | 47 |